Jürg R Pfister

Title: Jürg R Pfister: Innovator in Pulmonary Hypertension Treatment

Introduction

Jürg R Pfister is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary hypertension. With a total of two patents to his name, Pfister's work focuses on innovative compounds that offer new therapeutic options.

Latest Patents

Pfister's latest patents include the development of treprostinil derivative compounds and methods of using them. These compounds are represented by specific formulae, including pro-drugs for treprostinil and prostacyclin analogs. The primary applications of these compounds are in the treatment of pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH). The structures of these compounds can be tailored to meet the requirements for suitable treatment dosages, and they can also be utilized in transdermal applications.

Career Highlights

Jürg R Pfister is currently associated with Corsair Pharma, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments for serious health conditions, showcasing his commitment to improving patient outcomes.

Collaborations

Pfister collaborates with esteemed colleagues, including Cyrus K Becker and Meenakshi S Venkatraman. Their combined expertise contributes to the innovative environment at Corsair Pharma, Inc.

Conclusion

Jürg R Pfister's contributions to the field of pulmonary hypertension treatment through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmaceutical therapies.